Pharmafile Logo

The Opportunity for Women’s Health in Emerging Markets

June 3, 2016 | emerging markets 

Published in eyeforpharma April 2016 by Rachel Howard

In our latest article for eyeforpharma, Associate Director Rachel Howard looks at what we mean by “women’s health” and outlines some of the considerations for pharma companies who want to maximize their opportunity in emerging markets. Gender roles, societal norms, culture, demographics, lifestyle and religion all have an impact on women’s health, so Howard advises that pharma start by building a full understanding of women in the markets in which they hope to successfully operate.

http://www.researchpartnership.com/news/2016/04/article-the-opportunity-for-women%E2%80%99s-health-i…

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Free Thinking: Behavioural economics

Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

Article: The Colombia Conundrum

Published in eye for pharma 30 January by Marc Yates

Ageing in China: The Implications for Healthcare

Published in eye for pharma 12 December by Marc Yates

Exploring MINT: Part 4 - Turkey

In the fourth and final of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in...

Getting to grips with Russia’s healthcare market

As a non-Russian, trying to understand the complexities of the multiple overlapping levels of Russia’s healthcare system can be baffling at times. Information is often inaccessible or data simply doesn't...

Exploring MINT: Part 3 - Nigeria

In the third of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria.

Exploring MINT: Part 2 - Indonesia

In the second of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Indonesia, with...

Free Thinking: Leveraging the ASEAN Market

If you can only research one ASEAN market, which one do you choose?Our Free Thinking paper investigates the opportunities for pharma in ASEAN and outlines the factors you need to...

Free Thinking: Biosimilars: Friend or foe to healthcare?

Our Free Thinking white paper looks at the opportunities for biosimilars and the threats to innovator biologics.